Trials / Completed
CompletedNCT06381050
The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors
An Open-label, Multicenter, Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-7631 for Injection in Patients With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label, phase I clinical trial of SHR-7631 in patients with advanced solid tumors. The whole study is divided into three stages: dose escalation, dose expansion and efficacy expansion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-7631 | The total dosage of SHR-7631 was calculated according to the weight weighing results of the subjects before each administration, and was administered by intravenous drip. |
Timeline
- Start date
- 2024-05-24
- Primary completion
- 2025-03-21
- Completion
- 2025-03-21
- First posted
- 2024-04-24
- Last updated
- 2025-06-13
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06381050. Inclusion in this directory is not an endorsement.